References

1. WHO website

2. Department of Health. Yvette Cooper welcomes the impact of new meningitis C vaccine. Press release, 2000/018

3. Immunisation against Infectious Disease. Eds Salisbury D and Begg N HMSO 1996, p69

4. Data extrapolated from Immunisation against Infectious Disease. Eds Salisbury D and Begg N HMSO 1996, p67

5. Immunisation against Infectious Disease. Eds Salisbury D and Begg N HMSO 1996, p155

6. Ibid, p126

7. Ibid, p128

8. Ibid, p132

9. Data extrapolated from ibid, p125

10. Boag F. Hepatitis B: heterosexual transmission and vaccination strategies. Int J STD & AIDS 119; (2):318-24

11. Hoofnagle JH et al. Chronic type B hepatitis and the ‘healthy’ HbsAg carrier state. Hepatology 1987;7(4):758-63

12. Grosheide P and Van Damme P. Prevention and control of hepatitis ABPI in the community. Viral Hepatitis Prevention Board, WHO, 1996, p39

13. Immunisation against Infectious Disease. Eds Salisbury D and Begg N HMSO 1996, p167

14. Ament A, Baltussen R et al. In press

15. Immunisation against Infectious Disease. Eds Salisbury D and Begg N HMSO 1996, p113

16. Wakefield AJ et al. Ileal-lymphoid nodular hyperplasia, nonspecific colitis and pervasive developmental disorder in children. Lancet 1998; 351:1327-8

17. Peltola H et al. No evidence for measles, mumps and rubella vaccine associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1999; 353:2026-9

18. Taylor B et al. Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353:2026-9

19. Gillberg and Heijbel. Autism 1998; 2: 423-4

20. WHO website – Polio factsheet